{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T18:20:40Z","timestamp":1769278840879,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ymgme.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:43:45Z","timestamp":1563882225000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease"],"prefix":"10.1016","volume":"128","author":[{"given":"Yuliya","family":"Afinogenova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiapeng","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathaniel","family":"Kleytman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory","family":"Pastores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Lischuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramod K.","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"53","key":"10.1016\/j.ymgme.2019.07.014_bb0005","doi-asserted-by":"crossref","first-page":"41216","DOI":"10.1074\/jbc.X110.197954","article-title":"Benefits from unearthing \"a biochemical Rosetta stone\"","volume":"285","author":"Brady","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"9645","key":"10.1016\/j.ymgme.2019.07.014_bb0010","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher's disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ymgme.2019.07.014_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ymgme.2019.07.014_bb0020","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1172\/JCI117084","article-title":"Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease","volume":"93","author":"Hollak","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.ymgme.2019.07.014_bb0025","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/jbmr.1680","article-title":"Risk factors for fractures and avascular osteonecrosis in type 1 Gaucher disease: a study from the international collaborative Gaucher group (ICGG) Gaucher registry","volume":"27","author":"Khan","year":"2012","journal-title":"J. Bone Miner. Res."},{"issue":"5","key":"10.1016\/j.ymgme.2019.07.014_bb0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/humu.20676","article-title":"Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)","volume":"29","author":"Hruska","year":"2008","journal-title":"Hum. Mutat."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2019.07.014_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ymgme.2004.08.015","article-title":"Gaucher disease: complexity in a \"simple\" disorder","volume":"83","author":"Sidransky","year":"2004","journal-title":"Mol. Genet. Metab."},{"issue":"45","key":"10.1016\/j.ymgme.2019.07.014_bb0040","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ymgme.2019.07.014_bb0045","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bcmd.2016.12.002","article-title":"Validating glycoprotein non-metastatic melanoma B (gpNMB, osteoactivin), a new biomarker of Gaucher disease","volume":"68","author":"Murugesan","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2019.07.014_bb0050","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ymgme.2019.07.014_bb0055","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cytogfr.2018.04.003","article-title":"Molecular regulations and therapeutic targets of Gaucher disease","volume":"41","author":"Chen","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"5","key":"10.1016\/j.ymgme.2019.07.014_bb0060","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2214\/ajr.147.5.943","article-title":"Gaucher's disease type 1: assessment of bone involvement by CT and scintigraphy","volume":"147","author":"Hermann","year":"1986","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.ymgme.2019.07.014_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ebiom.2018.01.022","article-title":"Chitinase-3-like protein 1: a Progranulin downstream molecule and potential biomarker for Gaucher Disease","volume":"28","author":"Jian","year":"2018","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.ymgme.2019.07.014_bb0070","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar4406","article-title":"Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis","volume":"15","author":"Thurner","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.ymgme.2019.07.014_bb0075","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s10620-014-3089-3","article-title":"Proinflammatory progranulin antibodies in inflammatory bowel diseases","volume":"59","author":"Thurner","year":"2014","journal-title":"Dig. Dis. Sci."},{"issue":"6028","key":"10.1016\/j.ymgme.2019.07.014_bb0080","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1126\/science.1199214","article-title":"The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice","volume":"332","author":"Tang","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ymgme.2019.07.014_bb0085","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ebiom.2016.08.004","article-title":"Association between Progranulin and Gaucher Disease","volume":"11","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ymgme.2019.07.014_bb0090","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.10.010","article-title":"Progranulin recruits HSP70 to beta-Glucocerebrosidase and is therapeutic against Gaucher Disease","volume":"13","author":"Jian","year":"2016","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.ymgme.2019.07.014_bb0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.neurobiolaging.2007.08.022","article-title":"Prominent phenotypic variability associated with mutations in Progranulin","volume":"30","author":"Kelley","year":"2009","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.ymgme.2019.07.014_bb0100","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.molmed.2011.05.003","article-title":"Exploring the link between glucocerebrosidase mutations and parkinsonism","volume":"17","author":"Westbroek","year":"2011","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2019.07.014_bb0105","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.rmed.2010.02.026","article-title":"Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis","volume":"104","author":"Furuhashi","year":"2010","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.ymgme.2019.07.014_bb0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S0168-8278(00)80095-1","article-title":"Serum YKL-40 is increased in patients with hepatic fibrosis","volume":"32","author":"Johansen","year":"2000","journal-title":"J. Hepatol."},{"issue":"240","key":"10.1016\/j.ymgme.2019.07.014_bb0115","doi-asserted-by":"crossref","first-page":"240ra76","DOI":"10.1126\/scitranslmed.3007096","article-title":"Chitinase 3-like 1 suppresses injury and promotes fibroproliferative responses in mammalian lung fibrosis","volume":"6","author":"Zhou","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ymgme.2019.07.014_bb0120","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease","author":"Grabowski","year":"2014"},{"issue":"4","key":"10.1016\/j.ymgme.2019.07.014_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher's disease: clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"issue":"9","key":"10.1016\/j.ymgme.2019.07.014_bb0130","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3109\/10428194.2015.1004168","article-title":"Serum YKL-40: a new independent prognostic marker for skeletal complications in patients with multiple myeloma","volume":"56","author":"Mylin","year":"2015","journal-title":"Leuk. Lymphoma"},{"issue":"1","key":"10.1016\/j.ymgme.2019.07.014_bb0135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10735-006-9075-0","article-title":"YKL-40 protein expression in normal adult human tissues--an immunohistochemical study","volume":"38","author":"Ringsholt","year":"2007","journal-title":"J. Mol. Histol."},{"key":"10.1016\/j.ymgme.2019.07.014_bb0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.bone.2014.01.005","article-title":"Determination of chitinases family during osteoclastogenesis","volume":"61","author":"Di Rosa","year":"2014","journal-title":"Bone"},{"issue":"18","key":"10.1016\/j.ymgme.2019.07.014_bb0145","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","article-title":"Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses","volume":"19","author":"Vitner","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.ymgme.2019.07.014_bb0150","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1182\/blood.V96.5.1969","article-title":"Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K","volume":"96","author":"Moran","year":"2000","journal-title":"Blood"},{"issue":"36","key":"10.1016\/j.ymgme.2019.07.014_bb0155","doi-asserted-by":"crossref","first-page":"9678","DOI":"10.1021\/bi800699v","article-title":"Cathepsin D is the main lysosomal enzyme involved in the degradation of alpha-synuclein and generation of its carboxy-terminally truncated species","volume":"47","author":"Sevlever","year":"2008","journal-title":"Biochemistry"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219304536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719219304536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T23:26:35Z","timestamp":1761089195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719219304536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1096719219304536"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.07.014","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}